Aditi Sapre

Efficacy and Safety of Statin Therapy in Children With Familial Hypercholesterolemia

Saskia de Jongh, Leiv Ose, Tamás Szamosi et al. · Circulation · 2002 · 308 citations

Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients

Daniel M. Bloomfield, Gary L. Carlson, Aditi Sapre et al. · American Heart Journal · 2008 · 242 citations

Lipid Disorder, Cardiovascular Disease, Medicine +6

Efficacy and Safety of Ezetimibe Coadministered With Simvastatin in Patients With Primary Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled Trial

Anne C. Goldberg, Aditi Sapre, Ji Liu et al. · Mayo Clinic Proceedings · 2004 · 193 citations

Primary Hypercholesterolemia, Lipid Disorder, Cardiovascular Disease +9

A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia

Harold Bays, Leiv Ose, Neil J. Fraser et al. · Clinical Therapeutics · 2004 · 176 citations

Metabolic Syndrome, Thrombosis, Primary Hypercholesterolemia +12

Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study

John J.P. Kastelein, Joost Besseling, Sukrut Shah et al. · The Lancet · 2015 · 99 citations

Metabolic Syndrome, Lipid Disorder, Heterozygous Familial Hypercholesterolaemia +7